Evidence map›Paper›PMID 24064744›Full record

ArticleAmerican journal of epidemiology2013

Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009.

Ryan M Seals, Johnni Hansen, Ole Gredal, Marc G Weisskopf

Registry-linked trialAbstract read
In one paragraph

Article in American journal of epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02869048 (Amyotrophic Lateral Sclerosis and the Innate Immune System), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02869048 unknown statusnot on this mapstarted 2016, after this paper: background citation

Amyotrophic Lateral Sclerosis and the Innate Immune System

TypeobservationalSponsorRigshospitalet, DenmarkRan2016 to 2026Enrolled375ConditionsAmyotrophic Lateral Sclerosis, Neurodegenerative Disease, Motor Neuron Disease
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Spatial analyses of ALS incidence in Denmark over three decades.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryan M Seals
Johnni Hansen
Ole Gredal
Marc G Weisskopf

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
Training Program in Environmental EpidemiologyT32ES007069 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LADEN, FRANCINE · 1985 to 2024
$13.9M
Population-Based Study of Environmental Risk Factors for ALSR01ES019188 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI WEISSKOPF, MARC G · 2010 to 2014
$2.0M
NIEHS NIH HHS 5R01ES019188-02NIEHS NIH HHS P30 ES000002NIEHS NIH HHS R01 ES019188NIEHS NIH HHS T32 ES007069NIEHS NIH HHS T32 ES 07069
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a disease of the motor neuron with poorly understood etiology. Recent studies have suggested that the incidence rate of ALS and the rate of death from ALS are increasing, but it is unclear whether this is due to changing exposures or improvements in diagnosis. We used age-period-cohort models to investigate trends in ALS incidence (hospitalization) from 1982 to 2009 and ALS mortality from 1970 to 2009 in Denmark. Among those 45 years of age or older, 4,265 deaths (incidence rate = 5.35 per 100,000 person-years) and 3,228 incident diagnoses (incidence rate = 5.55 per 100,000 person-years) were recorded. Age-adjusted mortality rates increased by an average of 3.0% annually between 1970 and 2009 and by an average of 2.1% annually after 1982. Age-period-cohort analyses suggested that the full age-period-cohort model provided the best fit to the mortality data (P < 0.001), although restriction to the post-1982 period suggested that the age-cohort model provided the best fit. Age-adjusted incidence rates increased by 1.6% annually after 1982 (P < 0.001), which was best explained by the age-period model, with borderline significant cohort effects (P = 0.08). A consistent finding regardless of parameterization or data subset appeared to be an increase in ALS incidence and mortality rate with later birth cohorts, up to a birth year of at least 1910.

Indexed as

AgedAged, 80 and overAge DistributionAge FactorsAmyotrophic Lateral SclerosisCohort StudiesDenmarkHumansMiddle Agedage-period-cohort modelamyotrophic lateral sclerosisbrain disordersneurodegenerative disordersneuroepidemiology

Identifiers

PMID24064744
PMCPMC3792730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.